Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon Forms Alliance With Nonprofits, Hopes to Increase Use of Its Human siArray Library

NEW YORK, Oct. 6 (GenomeWeb News) - Nine nonprofit research organizations have formed the Genome-Wide RNAi Global Initiative, which aims to use Dharmacon's complete siRNA library to target genes throughout the human genome in functional-genomics research, the Lafayette, Colo.-based company said today.

 

The initial members of the initiative are mostly cancer-research institutions, many of which plan to incorporate the siRNA library into high-throughput screening facilities, the company said.

 

The founding members of the initiative are: The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital and Samuel Lunenfeld Research Institute at Mount Sinai Hospital, both with the University of Toronto; Cancer Research UK-funded scientists at the London Research Institute and the Institute of Cancer Research; the German Cancer Research Center; UNMC Eppley Cancer Center at the University of Nebraska Medical Center; the Netherlands Cancer Institute; the Scottish Centre for Genomic Technology and Informatics based at the University of Edinburgh Medical School; the University of Texas Southwestern Medical Center; and Yale University, Dharmacon said.

 

The Universityof Texas MD Anderson Cancer Center, the Cambridge Institute for Medical Research, and MRC Cancer Cell Unit are also expected to join the Global Initiative, pending final institutional approval, the company said. The firm expects the initiative to expand further with the addition of more members in the coming months, the statement said.

 

The first meeting of the Genome-Wide RNAi Global Initiative will take place in Bostonon Oct. 17 and 18, Dharmacon said.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.